Lymphadenopathy-Associated Virus/Human T-Lymphotropic Virus Type III in Allogeneic Bone Marrow Transplantation
Authors: Philippe Bierling, Catherine Cordonnier, Najib Duedari, Jean-Paul Vernant, Jacques Leibowitch, Dominique Mathez
Journal: Annals of Internal Medicine (1986)

Letters and Corrections1 January 1986Lymphadenopathy-Associated Virus/Human T-Lymphotropic Virus Type III in Allogeneic Bone Marrow TransplantationPHILIPPE BIERLING, M.D., CATHERINE CORDONNIER, M.D., NAJIB DUEDARI, M.D., JEAN-PAUL VERNANT, M.D., JACQUES LEIBOWITCH, M.D., DOMINIQUE MATHEZ, M.D.PHILIPPE BIERLING, M.D.Search for more papers by this author, CATHERINE CORDONNIER, M.D.Search for more papers by this author, NAJIB DUEDARI, M.D.Search for more papers by this author, JEAN-PAUL VERNANT, M.D.Search for more papers by this author, JACQUES LEIBOWITCH, M.D.Search for more papers by this author, DOMINIQUE MATHEZ, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-104-1-131 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTo the editor: The acquired immunodeficiency seen after bone marrow transplantation and that due to infection with the lymphadenopathy-associated virus/human T-lymphotropic virus type HI (LAV/HTLV-III) have many clinical and immunologic features in common. Marrow transplant recipients are at risk of LAV/HTLV-III infection given the considerable amount of transfused blood products they receive. A retrospective study was conducted in our institution to determine the role of LAV/HTLV-III in the immunodeficiency seen after bone marrow transplantation.Fifty unselected patients, for whom a serum sample collected at least 100 days after bone marrow transplantation was available, were included. All patients received an allogeneic...References1. MATHEZ D, LEIBOWITCH J, CATALAN P, ESSEX M, and ZAGURI D. HTLV-III and AIDS in France [Letter]. Lancet. 1984;1:799. CrossrefMedlineGoogle Scholar2. ATKINSON K, COOPER D, DODDS A, PENNY R, CANCANNON A, and BIGGS J. Evidence that immune deficiency after marrow transplantation is not caused by AIDS-associated retrovirus [Letter]. N Engl J Med. 1985;313:182. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAuthors: PHILIPPE BIERLING, M.D.; CATHERINE CORDONNIER, M.D.; NAJIB DUEDARI, M.D.; JEAN-PAUL VERNANT, M.D.; JACQUES LEIBOWITCH, M.D.; DOMINIQUE MATHEZ, M.D. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byThe HIV/AIDS epidemic: its evolutionary implications for human ecology with special reference to the immune systemFailure of allogeneic bone marrow transplantation to benefit HIV infectionHematological Support in Patients Undergoing Allogenetic Bone Marrow TransplantationAIDS AND RELATED SYNDROMES AS A VIRAL-INDUCED AUTOIMMUNE DISEASE OF THE IMMUNE SYSTEM: AN ANTI-MHC II DISORDER. THERAPEUTIC IMPLICATIONS 1 January 1986Volume 104, Issue 1Page: 131-132KeywordsBloodBone marrowBone marrow transplantationClinical immunologyImmunodeficienciesRetrospective studies ePublished: 1 December 2008 Issue Published: 1 January 1986 PDF downloadLoading ...